Latest filing published 16 Jan 2024 for EyePoint, Inc., €33.9M.
Filing timeline
BuySaleInsider track record
Therapeutics Ocumension: trading record in brief
This profile gathers the share dealings of Therapeutics Ocumension in EyePoint, Inc. Over a trading history stretching from 5 December 2023 to 11 January 2024, the count stands at 3 filings.
On the market, this insider has only sold: 3 sales, €51.9M in total. 2024 to date brings no purchases and 1 sale.
On 16 January 2024 came the latest disclosure, an open-market sale for €33.9M in EyePoint, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Therapeutics Ocumension
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,910,500 shares@ US$19.4571.5% of flowcommon stockSEC:0001840315-24-000002:0
- 266,242 shares@ US$18.41common stockSEC:0001840315-23-000007:1
- 733,758 shares@ US$19.9128.5% of flowcommon stockSEC:0001840315-23-000007:0
3 of 2 declarations
